Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.
about
Pyocyanina contributory factor in haem acquisition and virulence enhancement of Porphyromonas gingivalis in the lung [corrected]Contribution of Veillonella parvula to Pseudomonas aeruginosa-mediated pathogenicity in a murine tumor model system.Determining cystic fibrosis-affected lung microbiology: comparison of spontaneous and serially induced sputum samples by use of terminal restriction fragment length polymorphism profiling.Pseudomonas aeruginosa biofilm infections in cystic fibrosis: insights into pathogenic processes and treatment strategies.The role of the bacterial microbiome in lung diseaseEmergent bacteria in cystic fibrosis: in vitro biofilm formation and resilience under variable oxygen conditions.Ecological networking of cystic fibrosis lung infections.Reliability of quantitative real-time PCR for bacterial detection in cystic fibrosis airway specimensAntibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungiThe changing microbial epidemiology in cystic fibrosis.True microbiota involved in chronic lung infection of cystic fibrosis patients found by culturing and 16S rRNA gene analysis.The microorganisms in chronically infected end-stage and non-end-stage cystic fibrosis patients.Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures.Aspirated bile: a major host trigger modulating respiratory pathogen colonisation in cystic fibrosis patients.The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbationsClinical significance of microbial infection and adaptation in cystic fibrosis.Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy.Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbationsIs the improvement of CF patients, hospitalized for pulmonary exacerbation, correlated to a decrease in bacterial load?High individuality of respiratory bacterial communities in a large cohort of adult cystic fibrosis patients under continuous antibiotic treatment.Biogeochemical forces shape the composition and physiology of polymicrobial communities in the cystic fibrosis lung.Microbiome in cystic fibrosis: Shaping polymicrobial interactions for advances in antibiotic therapy.Rapid Detection of Emerging Pathogens and Loss of Microbial Diversity Associated with Severe Lung Disease in Cystic FibrosisThe bacterial microbiota in inflammatory lung diseasesThe Role of Short-Chain Fatty Acids, Produced by Anaerobic Bacteria, in the Cystic Fibrosis AirwayCystic fibrosis lung microbiome: opportunities to reconsider management of airway infection.The cystic fibrosis microbiome in an ecological perspective and its impact in antibiotic therapy.Can early Burkholderia cepacia complex infection in cystic fibrosis be eradicated with antibiotic therapy?Culture-Based and Culture-Independent Bacteriologic Analysis of Cystic Fibrosis Respiratory SpecimensA Winogradsky-based culture system shows an association between microbial fermentation and cystic fibrosis exacerbationLung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation.Update in cystic fibrosis 2009.The polymicrobial nature of airway infections in cystic fibrosis: Cangene Gold Medal Lecture.Anaerobic Pseudomonas aeruginosa and other obligately anaerobic bacterial biofilms growing in the thick airway mucus of chronically infected cystic fibrosis patients: an emerging paradigm or "Old Hat"?Differences of lung microbiome in patients with clinically stable and exacerbated bronchiectasis.The airway microbiota in early cystic fibrosis lung disease.A Different Microbiome Gene Repertoire in the Airways of Cystic Fibrosis Patients with Severe Lung Disease.Acquisition and adaptation of the airway microbiota in the early life of cystic fibrosis patients.Prevotella intermedia induces severe bacteremic pneumococcal pneumonia in mice with upregulated platelet-activating factor receptor expression.Microbes in bronchiectasis: the forest or the trees?
P2860
Q28543599-57845040-F61E-4F4B-B0BE-91145B4A98FAQ30614122-B67DA348-19EB-4746-91EB-203315B98CD0Q30882278-C0B95149-EE10-4919-9208-8751FE78AE82Q33522442-2AB130DB-4277-4713-88A6-136CCBC95D30Q33554623-18E26E39-A156-42DC-877F-3307C076EB99Q33609099-313A866F-BF9B-4AEF-B236-07BC168CAE75Q33767505-2C881793-354B-4595-9DFB-D57780415343Q33770039-10B9BEB0-13C6-41BA-9398-479C6FD387B4Q33792765-F8C26872-018E-4A5E-8529-80B3515CE5E5Q33825634-CB5AA5B0-1B16-4392-8DBD-B6F1B2AB1B74Q34051927-F9D3A202-80ED-46A6-946D-BDF01BD4B256Q34115440-46FD3145-AEF8-4B14-AE27-ACBE42DEC8D4Q34118967-39AF8A32-03E1-4045-B8B3-A9E386C1095BQ34277932-93A0708F-E8FE-4158-A797-6A628C9B75B5Q34437958-D4592988-43ED-43E0-BFEA-9FE14D642585Q34491552-BD0B739D-B879-4BBB-851E-43F9E582B72AQ34554419-FB590D77-411D-480C-9D5E-F2D6E25BEBA2Q34706914-F78EC6A0-EFB6-4EF1-AE3F-64616EA75623Q35060166-8C929320-6EFD-4E94-A5EC-77B685FCD456Q35074619-94C39180-14B7-4B69-B1B6-78622F9BABCDQ35124468-6F506CB6-95F9-4DE3-B52D-A5FBEEE86340Q35124580-1C126C9A-E4F2-4DE2-9CF7-5D31D605C1CDQ35602934-1114DFF9-DC80-43C2-9D4B-CFF013BA8788Q35677622-7D133C20-B2C9-4913-ABDE-64C8750CDEE4Q35743588-23957C9D-C3DB-4265-9BD9-CF36926BA0FEQ35763672-FA3C10B3-7BCE-4424-8EEB-3488476A1936Q35861377-E35323ED-EAC9-4488-9408-1B91D6826CB6Q36158785-598553C6-325C-4C0A-A892-F190AC809384Q36620854-BDF76E12-AFC9-4E5F-A350-F466EFC496EDQ36756544-DD48C58B-C4D0-43F4-8CB7-EE562FE17790Q37072994-70F5C86D-66AE-4A9D-A0F1-A62AC7BBE62BQ37704053-30FCF2BE-55FA-486D-AEDD-19716F72FA99Q37843465-29625FDA-8B2E-49B0-9B58-8FD9DB7AB0C1Q38026069-02DCE67A-8F4A-43C4-A6FA-5BDCD193133BQ38614140-1E0561FD-24FE-40F0-A302-BF71919AA6DDQ38641233-2B922636-8171-4A2C-A407-1C7A85E7599BQ38652042-499867A3-1A3E-44C2-A890-CC3B62905C0BQ38769187-161D3BC8-B4F0-4D00-B430-AD519C7AD118Q39029126-411AADE2-7DE8-4A50-80C5-1EB9D4C45AA6Q43774755-1AB37B20-9ACB-43F5-9A3D-EAC7A19902C6
P2860
Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.
@en
Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.
@nl
type
label
Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.
@en
Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.
@nl
prefLabel
Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.
@en
Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.
@nl
P2093
P921
P1476
Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.
@en
P2093
B Wollschläger
C Rintelen
D Worlitzsch
M Borneff-Lipp
P304
P356
10.1111/J.1469-0691.2008.02659.X
P577
2009-01-22T00:00:00Z